pindolol has been researched along with Complications of Diabetes Mellitus in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amour, J | 1 |
| Loyer, X | 1 |
| Michelet, P | 1 |
| Birenbaum, A | 1 |
| Riou, B | 1 |
| Heymes, C | 1 |
| Certin, M | 1 |
| Wechsler, B | 1 |
| Bletry, O | 1 |
| Godeau, P | 1 |
2 other studies available for pindolol and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Preservation of the positive lusitropic effect of beta-adrenoceptors stimulation in diabetic cardiomyopathy.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiomyopathies; Colforsin; Diabete | 2008 |
[Letter: Hypoglycemia during beta blocking treatment].
Topics: Angina Pectoris; Diabetes Complications; Fasting; Humans; Hypoglycemia; Insulin; Insulin Secretion; | 1976 |